Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Public consultation for a medical device treating high-risk soft tissue sarcoma now opened

The EUnetHTA has started a new collaborative assessment of a medical device for the treatment of high-risk soft tissue sarcoma. For this specific assessment, patient groups’ input is required. The EUnetHTA are looking for patient organizations throughout Europe to provide an opinion on the organizational perspective of the treatment of high-risk soft tissue sarcoma. The term “patient” refers to anyone living with, or who have lived with, the condition for which the new medical device is indicated. The input provided will inform the scope of the assessment, e.g. on patient-relevant outcomes or possible neglected outcomes, as well as on the burden of disease.

The consultation closes on November 30, 2018.

See the full report and the questionnaire in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.